Gentiopicroside inhibits the progression of gastric cancer through modulating EGFR/PI3K/AKT signaling pathway

Gentiopicroside inhibits the progression of gastric cancer through modulating EGFR/PI3K/AKT signaling pathway

Abstract Background This study was designed to clarify the function and potential mechanism of gentiopicroside (GPS) in regulating the malignant progression of gastric cancer (GC) through in vitro cellular experiments and in vivo animal models. Methods AGS and HGC27 cells were divided into control g...

Full description

Bibliographic Details
Main Authors:	Qishuai Chen, Tongtong Zhang, Bingjun Li, Zhenguo Zhu, Xiaomin Ma, Yun Zhang, Linchuan Li, Jiankang Zhu, Guangyong Zhang
Format:	Article
Language:	English
Published:	BMC 2024-01-01
Series:	European Journal of Medical Research
Subjects:	Gentiopicroside PI3K/AKT signaling pathway EGFR Gastric cancer Apoptosis
Online Access:	https://doi.org/10.1186/s40001-024-01637-6

Similar Items

Gentiopicroside targets PAQR3 to activate the PI3K/AKT signaling pathway and ameliorate disordered glucose and lipid metabolism
by: Haiming Xiao, et al.
Published: (2022-06-01)

Gentiopicroside ameliorates the lipopolysaccharide-induced inflammatory response and hypertrophy in chondrocytes
by: Longfei Li, et al.
Published: (2024-03-01)

Gentiopicroside modulates glucose homeostasis in high-fat-diet and streptozotocin-induced type 2 diabetic mice
by: Xing Wang, et al.
Published: (2023-08-01)

Study of the mechanism by gentiopicroside protects against skin fibroblast glycation damage via the RAGE pathway
by: Chunyu Chen, et al.
Published: (2024-02-01)

Exploration of Hepatoprotective Effect of Gentiopicroside on Alpha-Naphthylisothiocyanate-Induced Cholestatic Liver Injury in Rats by Comprehensive Proteomic and Metabolomic Signatures
by: Han Han, et al.
Published: (2018-09-01)

Engineering of gentiopicroside-producing yeast strain using low-energy ion implantation mediated synthetic biology
by: Ting Wang, et al.
Published: (2016-07-01)

Compound Kushen injection inhibits EMT of gastric cancer cells via the PI3K/AKT pathway
by: Luo Li, et al.
Published: (2022-05-01)

Synthesis and Biological Evaluation of Gentiopicroside Derivatives as Novel Cyclooxygenase-2 Inhibitors with Anti-Inflammatory Activity
by: Ren G, et al.
Published: (2023-03-01)

Gentiopicroside—An Insight into Its Pharmacological Significance and Future Perspectives
by: Lemonia Antoniadi, et al.
Published: (2023-12-01)

Co-Targeting the EGFR and PI3K/Akt Pathway to Overcome Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma: What about Autophagy?
by: Hannah Zaryouh, et al.
Published: (2022-12-01)

Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma
by: Jieun Bang, et al.
Published: (2023-08-01)

Preparation, Characterization, and In Vivo Evaluation of Gentiopicroside-Phospholipid Complex (GTP-PC) and Its Self-Nanoemulsion Drug Delivery System (GTP-PC-SNEDDS)
by: Yingpeng Tong, et al.
Published: (2023-01-01)

Gentiopicroside improves high-fat diet-induced NAFLD in association with modulation of host serum metabolome and gut microbiome in mice
by: Lijuan Wang, et al.
Published: (2023-08-01)

EGFR/PI3K/Akt/mTOR pathway in head and neck squamous cell carcinoma patients with different HPV status
by: Anna Janecka-Widła, et al.
Published: (2022-02-01)

PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis
by: Wenting Xu, et al.
Published: (2018-08-01)

CRISPLD1 promotes gastric cancer progression by regulating the Ca2+/PI3K-AKT signaling pathway
by: Liqiang Hu, et al.
Published: (2024-03-01)

Gentiopicroside improves non-alcoholic steatohepatitis by activating PPARα and suppressing HIF1
by: Chaoyuan Huang, et al.
Published: (2024-03-01)

A New EGFR Inhibitor from <i>Ficus benghalensis</i> Exerted Potential Anti-Inflammatory Activity via Akt/PI3K Pathway Inhibition
by: Rania Alaaeldin, et al.
Published: (2022-07-01)

Gentiopicroside Ameliorates Diabetic Renal Tubulointerstitial Fibrosis via Inhibiting the AT1R/CK2/NF-κB Pathway
by: Zhanchi Xu, et al.
Published: (2022-06-01)

Relation of EGFR/PI3K/AKT signaling components with tamoxifen efficacy in patients with estrogen-dependent breast cancer
by: T. A. Dronova, et al.
Published: (2018-11-01)

Periodic Mechanical Stress Activates PKCδ-Dependent EGFR Mitogenic Signals in Rat Chondrocytes via PI3K-Akt and ERK1/2
by: Peng He, et al.
Published: (2016-09-01)

LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway
by: Yanxia Huang, et al.
Published: (2017-12-01)

SCD1 is required for EGFR-targeting cancer therapy of lung cancer via re-activation of EGFR/PI3K/AKT signals
by: Kelin She, et al.
Published: (2019-04-01)

Vortioxetine induces apoptosis and autophagy of gastric cancer AGS cells via the PI3K/AKT pathway
by: Gao‐Bo Lv, et al.
Published: (2020-10-01)

Long Noncoding RNA EGFR-AS1 Promotes Cell Proliferation by Increasing EGFR mRNA Stability in Gastric Cancer
by: Jiaojiao Hu, et al.
Published: (2018-08-01)

Gentiopicroside-Loaded Chitosan Nanoparticles Inhibit TNF-α-Induced Proliferation and Inflammatory Response in HaCaT Keratinocytes and Ameliorate Imiquimod-Induced Dermatitis Lesions in Mice
by: Zhao K, et al.
Published: (2023-07-01)

FIP-nha, a fungal immunomodulatory protein from Nectria haematococca, induces apoptosis and autophagy in human gastric cancer cells via blocking the EGFR-mediated STAT3/Akt signaling pathway
by: Shu-Ying Li, et al.
Published: (2022-07-01)

Gallic acid suppresses the progression of triple-negative breast cancer HCC1806 cells via modulating PI3K/AKT/EGFR and MAPK signaling pathways
by: Si Lin, et al.
Published: (2022-11-01)

MiR-489 inhibited the development of gastric cancer via regulating HDAC7 and PI3K/AKT pathway
by: Haiyan Zhang, et al.
Published: (2020-04-01)

The distribution, uses, and characteristic components of gentianaceae plants in China
by: Han Cheng, et al.
Published: (2021-01-01)

Oncogenic transmembrane protein 158 drives the PI3K/Akt signaling pathway to accelerate gastric cancer cell growth
by: Xiaoting Cui, et al.
Published: (2023-11-01)

Cystathionine-β-synthase is essential for AKT-induced senescence and suppresses the development of gastric cancers with PI3K/AKT activation
by: Haoran Zhu, et al.
Published: (2022-06-01)

The Role of Akt in Acquired Cetuximab Resistant Head and Neck Squamous Cell Carcinoma: An In Vitro Study on a Novel Combination Strategy
by: Hannah Zaryouh, et al.
Published: (2021-09-01)

Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K‐Akt signaling in gastric cancer
by: Cheng Zhang, et al.
Published: (2019-08-01)

Eriodictyol Suppresses Gastric Cancer Cells via Inhibition of PI3K/AKT Pathway
by: Hui Shan, et al.
Published: (2022-11-01)

The regulatory ZFAS1/miR-150/ST6GAL1 crosstalk modulates sialylation of EGFR via PI3K/Akt pathway in T-cell acute lymphoblastic leukemia
by: Qianqian Liu, et al.
Published: (2019-05-01)

An EGFR and AKT Signaling Pathway was Identified with Mediation Model in Osteosarcomas Clinical Study
by: Yu Shyr, et al.
Published: (2007-01-01)

MBD3 promotes epithelial-mesenchymal transition in gastric cancer cells by upregulating ACTG1 via the PI3K/AKT pathway
by: Huizhi Wang, et al.
Published: (2024-01-01)

miR-30b-5p inhibits proliferation, invasion, and migration of papillary thyroid cancer by targeting GALNT7 via the EGFR/PI3K/AKT pathway
by: Ye Wang, et al.
Published: (2021-11-01)

FGFC1 Selectively Inhibits Erlotinib-Resistant Non-Small Cell Lung Cancer via Elevation of ROS Mediated by the EGFR/PI3K/Akt/mTOR Pathway
by: Shike Yan, et al.
Published: (2022-01-01)